Effects of isoflavone aglycone-rich fermented soybean paste extracts on osteoblastic differentiation of MG-63 cells

Journal of Applied Biological Chemistry

Volumn 53, Issue 6, 2010, Pages 803-809

  Jung, Won Kyo ^a   Choi, Il Whan ^b   Hong, Go Eun ^c   Pyun, Chang Won ^c   Park, Keun kyu ^c   Park, Pyo Jam ^d   Seo, Su Kil ^b   Choi, Yung Hyun ^e   Lee, Chi Ho ^c  

^a Chosun University   (South Korea)

^b Inje University   (South Korea)

^c Konkuk University   (South Korea)

^d Konkuk University   (South Korea)

^e Dong Eui University   (South Korea)

Author keywords

Alkaline phosphatase; Isoflavone aglycones rich Korean fermented soybean paste extracts; Mineralization; Osteoblastic differentiation; Osteocalcin; Type I collagen

Indexed keywords

GLYCINE MAX;

EID: 78751547973     PISSN: 19760442     EISSN: None     Source Type: Journal    
DOI: 10.3839/jksabc.2010.121     Document Type: Article

References (23)

1. Anderson JW, Johnstone BM, and Cook-Newell ME (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333, 276-282.
2. Anthony MS (2000) Soy and cardiovascular disease: cholesterol lowering and beyond. J Nutr 130, 662S-663S.
3. Aubin JE, Liu F, Malval L, and Gupta AK (1995) Osteoblast and chondroblast differentiation. Bone 17, 77S-83S.
4. Berg C, Neumeyer K, and Kirkpatrick P (2003) Teriparatide. Nat Rev Drug Discov 2, 257-258.
5. Choi YB and Sohn HS (1998) Isoflavone content in Korean fermented and unfermented soybean foods. Korean J Food Sci Technol 30, 745-750.
6. Coward L, Barnes NC, Setchell KDR, and Barnes S (1993) Genistein, daidzein, and their β-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets. J Agric Food Chem 41, 1961-1967.
7. Ducy P, Schinke T, and Karsenty G (2000) The osteoblast: a sophisticated fibroblast under central surveillance. Science 289, 1501-1504.
8. Eichner A, Brock J, Heldi CH, and Souchelnytskyi S (2002) Bone morphogenetic protein-7 (OP1) and transforming growth factor-beta1 modulate 1,25(OH)2-vitamin D3- induced differentiation of human osteoblasts. Exp Cell Res 275, 132-142.
9. 2+]. J Cell Biol 140, 325-334.
10. Hsu YL, Chang JK, Tsai CH, Chang Chien TT, and Kuo PL (2007) Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogenactivated protein kinase pathway. Biochem Pharmacol 73, 504-514.
11. Kuo PL, Hsu YL, Chang CH, and Chang JK (2005) Ostholemediated celldifferentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells. J Pharmacol Exp Ther 314, 1290-1299.
12. Lichtenstein AH (1998) Soy protein, isoflavones and cardiovascular disease risk. J Nutr 128, 1589-1592.
13. Lichtenstein AH (2001) Got soy? Am J Clin Nutr 73, 667-668.
14. Mark M (2007) Isoflavones. In Encyclopedia of Dietary Supplements, Coates P, Blackman MR, Cragg G, Levine M, Moss J, and White J (eds.), pp. 363-420. Marcel Dekker Ltd. NewYork, NY, USA.
15. McCue PP and Shetty K (2005) Phenolic antioxidant mobilization during yogurt production from soymilk using Kefir cultures. Process Biochem 40, 1791-1797.
16. Morris C, Thorpe J, Ambrosio L, and Santin M (2006) The soybean isoflavone genistein induces differentiation of MG63 human osteosarcoma osteoblasts. J Nutr 136, 1166-1170.
17. Nam HY, Min SG, Shin HC, Kim HY, Fukushima M, Han KH, Park WJ, Choi KD, and Lee CH (2005) The protective effects of isoflavone extracted from soybean paste in free radical initiator treated rats. Food Sci Biotechnol 14, 586-592.
18. Ohta T, Nakatsugi S, Watanabe K, Kawamori T, Ishikawa F, Morotomi M, Sugie S, Toda T, Sugimura T, and Wakabayashi K (2000) Inhibitory effects of Bifidobacteriumfermented soy milk on 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine-induced rat mammary carcinogenesis with a partial contribution of its component isoflavones. Carcinogenesis 21, 937-941.
19. Omoni AO and Aluko RE (2005) Soybean foods and their benefits: Potential mechanisms of action. Nutr Rev 63, 272-283.
20. Rodan GA and Martin TJ (2000) Therapeutic approaches to bone diseases. Science 289, 1508-1514.
21. Setchell KD, Brown NM, and Lydeking-Olsen E (2002) The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. J Nutr 132, 3577-3584.
22. Shin ZI, Yu R, Park SA, Chung DK, Ahn CW, Nam HS, Kim KS, and Lee HJ (2001) His-His-Leu, an angiotensin I converting enzyme inhibitory peptide derived from korean soybean paste, exerts antihypertensive activity in vivo. J Agric Food Chem 49, 3004-3009.
23. Yamabe S, Kobayashi-Hattori K, Kaneko K, Endo H, and Takita T (2007) Effect of soybean varieties on the content and composition of isoflavone in rice-koji miso. Food Chem 100, 369-374.